Acceptability of and Barriers to Human Papillomavirus Vaccination in China: A Systematic Review of the Chinese and English Scientific Literature

Overview

Journal Eur J Cancer Care (Engl)

Publisher Wiley

Specialties Nursing
Oncology

Date 2022 Mar 1

PMID 35229931

Authors

Du Wang

Jing Wu

Jianshu Du

Haley Ong

Biwei Tang

Marshall Dozier

David Weller

Christine Campbell

Affiliations

Soon will be listed here.

Abstract

Introduction: Widespread adoption of the human papillomavirus (HPV) vaccine will require population acceptance and tailoring of immunisation services to community needs and preferences. We examined peer-reviewed publications on the acceptability of and barriers to the HPV vaccine across China.

Methods: We searched English (MEDLINE, Embase, and Web of Science) and Chinese (CNKI, VIP, Wanfang data) databases between 1 January 2006 and 31 December 2017. We adopted a narrative approach for data synthesis.

Results: We identified 73 studies. The overall median acceptability of HPV vaccine was 71.8% (Q1-Q3: 58.6%-81%). Low levels of acceptability (<40%) of HPV vaccine were found in eastern regions of China. The largest differences of acceptability were observed between rural western regions (all >90%) and urban eastern regions (all <35%). Despite these regional variations, common barriers to HPV vaccine acceptance were concerns about vaccine safety, uncertainty over vaccine effectiveness, low perceived risk of cervical cancer and the price of the vaccine. The level of willingness to pay for the HPV vaccine (over 153 US dollars) was very low (<7%).

Conclusion: The acceptability of and attitudes towards HPV vaccine vary by regions and populations across China. HPV vaccination programmes will need to tailor service delivery as well as information materials to take account of regional concerns.

Citing Articles

Beyond health: exploring women's socio-cultural motivations for HPV vaccination.

Xu S, Zhang W, Zhang Y Int J Qual Stud Health Well-being. 2024; 19(1):2424494.

PMID: 39556005 PMC: 11574947. DOI: 10.1080/17482631.2024.2424494.

Inequities in human papillomavirus vaccination among children aged 9-14 years old under constrained vaccine supply in China.

Wang X, Pan J, Yan B, Zhang R, Yang T, Zhou X Int J Equity Health. 2024; 23(1):112.

PMID: 38822383 PMC: 11141026. DOI: 10.1186/s12939-024-02199-z.

Between now and later: a mixed methods study of HPV vaccination delay among Chinese caregivers in urban Chengdu, China.

Yim V, Wang Q, Li Y, Qin C, Tang W, Tang S BMC Public Health. 2024; 24(1):183.

PMID: 38225563 PMC: 10790461. DOI: 10.1186/s12889-024-17697-6.

The coverage and challenges of increasing uptake of non-National Immunization Program vaccines in China: a scoping review.

Jiang M, Chen S, Yan X, Ying X, Tang S Infect Dis Poverty. 2023; 12(1):114.

PMID: 38062480 PMC: 10704715. DOI: 10.1186/s40249-023-01150-8.

Lower rate of mpox vaccination hesitancy and medical consultation among Chinese men who have sex with men living with HIV in comparison with those living without HIV: A national observational study.

Zheng M, Du M, Yang G, Yao Y, Qian X, Zhi Y Hum Vaccin Immunother. 2023; 19(3):2290788.

PMID: 38054460 PMC: 10760384. DOI: 10.1080/21645515.2023.2290788.

References

Zhang S, Pan X, Wang S, Yang C, Gao X, Wang Z . Knowledge of human papillomavirus vaccination and related factors among parents of young adolescents: a nationwide survey in China. Ann Epidemiol. 2015; 25(4):231-5. DOI: 10.1016/j.annepidem.2014.12.009. View

Santhanes D, Yong C, Yap Y, San Saw P, Chaiyakunapruk N, Khan T . Factors influencing intention to obtain the HPV vaccine in South East Asian and Western Pacific regions: A systematic review and meta-analysis. Sci Rep. 2018; 8(1):3640. PMC: 5832144. DOI: 10.1038/s41598-018-21912-x. View

Zou H, Wang W, Ma Y, Wang Y, Zhao F, Wang S . How university students view human papillomavirus (HPV) vaccination: A cross-sectional study in Jinan, China. Hum Vaccin Immunother. 2015; 12(1):39-46. PMC: 4962712. DOI: 10.1080/21645515.2015.1072667. View

Li J, Li L, Ma J, Wei L, Niyazi M, Li C . Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China. Vaccine. 2009; 27(8):1210-5. DOI: 10.1016/j.vaccine.2008.12.020. View

Fu C, Pan X, Zhao Z, Saheb-Kashaf M, Chen F, Wen Y . Knowledge, perceptions and acceptability of HPV vaccination among medical students in Chongqing, China. Asian Pac J Cancer Prev. 2014; 15(15):6187-93. DOI: 10.7314/apjcp.2014.15.15.6187. View

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009; 339:b2535. PMC: 2714657. DOI: 10.1136/bmj.b2535. View

Hu S, Zheng R, Zhao F, Zhang S, Chen W, Qiao Y . [Trend analysis of cervical cancer incidence and mortality rates in Chinese women during 1989-2008]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2014; 36(2):119-25. DOI: 10.3881/j.issn.1000-503X.2014.02.001. View

Zhang Y, Wang Y, Liu L, Fan Y, Liu Z, Wang Y . Awareness and knowledge about human papillomavirus vaccination and its acceptance in China: a meta-analysis of 58 observational studies. BMC Public Health. 2016; 16:216. PMC: 4776385. DOI: 10.1186/s12889-016-2873-8. View

Wang Z, Wang J, Fang Y, Gross D, Wong M, Wong E . Parental acceptability of HPV vaccination for boys and girls aged 9-13 years in China - A population-based study. Vaccine. 2018; 36(19):2657-2665. DOI: 10.1016/j.vaccine.2018.03.057. View

10.

Gu C, Niccolai L, Yang S, Wang X, Tao L . Human papillomavirus vaccine acceptability among female undergraduate students in China: the role of knowledge and psychosocial factors. J Clin Nurs. 2015; 24(19-20):2765-78. DOI: 10.1111/jocn.12871. View

11.

Wang D, Wu J, Du J, Ong H, Tang B, Dozier M . Acceptability of and barriers to human papillomavirus vaccination in China: A systematic review of the Chinese and English scientific literature. Eur J Cancer Care (Engl). 2022; 31(3):e13566. PMC: 9287030. DOI: 10.1111/ecc.13566. View

12.

Hu D, Martin C, Dredze M, Broniatowski D . Chinese social media suggest decreased vaccine acceptance in China: An observational study on Weibo following the 2018 Changchun Changsheng vaccine incident. Vaccine. 2020; 38(13):2764-2770. PMC: 7211271. DOI: 10.1016/j.vaccine.2020.02.027. View

13.

Pan X, Zhao Z, Sun J, Chen F, Wen Q, Liu K . Acceptability and correlates of primary and secondary prevention of cervical cancer among medical students in southwest China: implications for cancer education. PLoS One. 2014; 9(10):e110353. PMC: 4215919. DOI: 10.1371/journal.pone.0110353. View

14.

Brisson M, Kim J, Canfell K, Drolet M, Gingras G, Burger E . Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020; 395(10224):575-590. PMC: 7043009. DOI: 10.1016/S0140-6736(20)30068-4. View

15.

Wang S, Zhang S, Pan X, Ren Z, Yang C, Wang Z . Human papillomavirus vaccine awareness, acceptability, and decision-making factors among Chinese college students. Asian Pac J Cancer Prev. 2014; 15(7):3239-45. DOI: 10.7314/apjcp.2014.15.7.3239. View

16.

Zhao F, Tiggelaar S, Hu S, Zhao N, Hong Y, Niyazi M . A multi-center survey of HPV knowledge and attitudes toward HPV vaccination among women, government officials, and medical personnel in China. Asian Pac J Cancer Prev. 2012; 13(5):2369-78. PMC: 5463422. DOI: 10.7314/apjcp.2012.13.5.2369. View

17.

Hong Y, Zhang C, Li X, Lin D, Liu Y . HPV and cervical cancer related knowledge, awareness and testing behaviors in a community sample of female sex workers in China. BMC Public Health. 2013; 13:696. PMC: 3733604. DOI: 10.1186/1471-2458-13-696. View

18.

Levin C, Sharma M, Olson Z, Verguet S, Shi J, Wang S . An extended cost-effectiveness analysis of publicly financed HPV vaccination to prevent cervical cancer in China. Vaccine. 2015; 33(24):2830-41. DOI: 10.1016/j.vaccine.2015.02.052. View

19.

Pan X, Li R, Pan A, Larson H . Human papillomavirus vaccine approval in China: a major step forward but challenges ahead. Lancet Infect Dis. 2016; 16(12):1322-1323. DOI: 10.1016/S1473-3099(16)30450-9. View

20.

Chang I, Huang R, He W, Zhang S, Wang S, Zhao F . Effect of an educational intervention on HPV knowledge and vaccine attitudes among urban employed women and female undergraduate students in China: a cross-sectional study. BMC Public Health. 2013; 13:916. PMC: 3852612. DOI: 10.1186/1471-2458-13-916. View